Blick ins Buch

Methods of Cancer Diagnosis, Therapy, and Prognosis

Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine Cancer, Skin Cancer, Leukemia, Multiple Myeloma and Sarcoma

M. A. Hayat (Herausgeber)

Buch | Hardcover

484 Seiten

2009
Springer (Verlag)
978-90-481-2917-1 (ISBN)

Lese- und Medienproben

Blick ins Buch (midvox)

Artikel merken

This volume presents a detailed survey of cancers. This volume was written by of various methodologies related to diag- 94 oncologists representing 13 countries. nosis, therapy, and prognosis of ovar- Their practical experience highlights their ian cancer, renal cancer, urinary bladder writings, which should build and further cancer, and cervical uterine cancer, while the endeavors of the readers in this imp- the already published Volumes 1–5 detail tant area of disease. The text of each c- similar aspects of breast, lung, prostate, cer type is divided into subheadings for liver, gastrointestinal, colorectal, and bil- the convenience of the readers. It is my iary tract carcinomas. hope that the current volume will join the It is well established that cancer is the preceding volumes of this series for assi- deadliest of human diseases. The follow- ing in the more complete understanding ing estimated global incidence of seven of globally relevant cancer syndromes. types of cancers discussed in this volume There exists a tremendous, urgent demand indicated the seriousness of this malig- by the public on the scientific community nancy. to address cancer prevention, diagnosis, treatment, and hopefully cures. Cervical uterine cancer 493,342 I am grateful to the contributors for their Urinary bladder cancer 357,000 promptness accepting my suggestions. I respect their dedication and diligent work Leukemia 300,522 in sharing their invaluable knowledge with Renal cancer 208,480 the public through this series.

Ovarian Cancer.- Identification of Biomarkers for Clear Cell Ovarian Adenocarcinoma.- Ovarian Carcinoma: Diagnostic Immunohistochemistry of MUCIN4 (MUC4).- Distinguishing Benign from Malignant Complex Adnexal Masses in Ovarian Cancer: Two-Dimensional Power-Doppler Imaging.- Subgroups of Ovarian Carinoma: Identification Using Differential Gene Expression.- Sertoliform Endometrioid Carcinoma of the Ovary: Diagnosis and Prognosis.- Role of MUC16 (CA125) in the Pathogenesis of Epithelial Ovarian Cancer.- Clear Cell Carcinoma of the Ovary: Prognosis Using Cytoreductive Surgery.- Advanced Ovarian Cancer: Prediction of Surgical Outcomes Using Computed Tomography.- Renal Cancer.- Renal Cell Carcinoma: Follow-Up with Magnetic Resonance Imaging After Percutaneous Radiofrequency Ablation.- Metastatic Kidney Cancer: Treatment with Infusional Interleukin-2 Plus Famotidine.- Renal Cell Carcinoma: Preoperative Treatment with Cytokines Followed by Surgery.- Metastatic Renal Cell Carcinoma: Use of Bcl-2 and Fas to Predict Responses to Immunotherapy.- Wilms Tumor: Prognosis Using Microvessel Density.- Urogenitary Tract Cancer.- Adenomatoid Tumor of the Adrenal Gland: Differential Diagnosis Using Immunohistochemistry.- Testicular Cancer: Post-Chemotherapy Retroperitoneal Lymph Node Dissection.- Survivors of Germ-Cell Testicular Cancer: Increased Risk of Second Primary Tumors.- Urinary Bladder Cancer.- Urothelial Bladder Cancer: Screening with Urine-Based Tumor Markers.- Detection of OCT-4 in Bladder Cancer: Role of Cancer Stem Cell.- Cervical Uterine Cancer.- Uterine Cervical Glandular Lesions: Differentiation Using Immunohistochemistry of Mucins.- Uterine Cervical Carcinoma: Preoperative Magnetic Resonance Imaging Staging.- Cancer Imaging and Intracavitary Brachytherapy for Cervical Cancer.- Cervical Cancer: Methods for Assessing the Quality of Life.- Cervical Cancer: Positron Emission Tomography and Positron Emission Tomography/Computed Tomography.- Endometrial Cancer: Indoleamine 2,3-Dioxygenase as a Prognostic Indicator.- Skin Cancer.- Neurofibromatosis Type 1-Associated Malignant Melanoma: Molecular Evidence of Inactivation of the NF1 Gene.- Malignant Melanoma: Localisation and Characterization Using Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography.- Malignant Melanoma Versus Deep Penetrating Nevus: Diagnostic and Prognostic Immunohistochemistry of Dipeptidyl Peptidase IV (Methodology).- Nonmelanoma Skin Cancer: Use of Epha1 Receptor as a Prognostic Marker.- Leukemia.- Pretreated Chronic Lymphocytic Leukemia: Use of Alemtuzumab.- Multiple Myeloma.- Immunotherapeutic Strategies, Radiotherapy, and Targeted Radionuclide Therapy Approaches for the Treatment of Multiple Myeloma.- Sarcoma.- Low Grade Fibromyxoid Sarcoma: Diagnosis by Detecting FUS-CREB3L2 Fusion Gene Using Reverse Transcription–Polymerase Chain Reaction.- Synovial Sarcoma: Role of TLE1 as a Diagnostic Immunohistochemical Marker.- The Immunohistochemistry of Kaposi’s Sarcoma.- Synovial Sarcoma: Role of Immunohistochemistry and Molecular Genetics in Diagnosis and Prognosis.- Sarcoma: Treatment with Ecteinascidin-743.

Erscheint lt. Verlag	18.12.2009
Reihe/Serie	Methods of Cancer Diagnosis, Therapy and Prognosis ; 6
Zusatzinfo	XLIV, 484 p.
Verlagsort	Dordrecht
Sprache	englisch
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Chirurgie
	Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie
	Medizin / Pharmazie ► Medizinische Fachgebiete ► Radiologie / Bildgebende Verfahren
	Medizin / Pharmazie ► Pflege
	Studium ► 2. Studienabschnitt (Klinik) ► Anamnese / Körperliche Untersuchung
ISBN-10	90-481-2917-6 / 9048129176
ISBN-13	978-90-481-2917-1 / 9789048129171
Zustand	Neuware